GlycoMimetics Inc. (GLYC)
NASDAQ: GLYC
· Real-Time Price · USD
0.25
0.01 (4.60%)
At close: May 15, 2025, 3:59 PM
0.27
8.61%
Pre-market: May 16, 2025, 04:18 AM EDT
4.60% (1D)
| Bid | 0.26 |
| Market Cap | 15.97M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -37.88M |
| EPS (ttm) | -0.59 |
| PE Ratio (ttm) | -0.42 |
| Forward PE | -7.94 |
| Analyst | n/a |
| Ask | 0.27 |
| Volume | 763,838 |
| Avg. Volume (20D) | 1,250,242 |
| Open | 0.23 |
| Previous Close | 0.24 |
| Day's Range | 0.23 - 0.25 |
| 52-Week Range | 0.14 - 0.63 |
| Beta | 1.70 |
About GLYC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GLYC
Website n/a
6 months ago
+191.32%
GlycoMimetics shares are trading higher after the ...
Unlock content with
Pro Subscription
10 months ago
+25.28%
GlycoMimetics shares are trading higher after the company disclosed that Chief Medical Officer Edwin Rock bought 305,000 shares at an average price of $0.26 per share.
